BTIG reaffirms Buy on Adaptive Biotechnologies; $34 target
BTIG maintained a Buy rating on Adaptive Biotechnologies with a $34.00 price target, implying 22.0% upside versus the Sep 21 close of $27.86.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.